Generation Bio Ownership | Who Owns Generation Bio?
Generation Bio Ownership Summary
Generation Bio is owned by 11.57% institutional investors, 14.29% insiders, and 74.14% retail investors. Blackrock is the largest institutional shareholder, holding 4.96% of GBIO shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 7.09% of its assets in Generation Bio shares.
GBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Generation Bio | 11.57% | 14.29% | 74.14% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 3.29M | 4.96% | $9.29M |
| Bank of america corp /de/ | 2.98M | 4.49% | $8.41M |
| Renaissance | 287.61K | 4.27% | $1.63M |
| Artal group | 2.83M | 4.26% | $7.98M |
| Vanguard group | 229.83K | 3.41% | $1.31M |
| Ubs group | 164.72K | 2.45% | $935.59K |
| Morgan stanley | 161.38K | 2.40% | $916.63K |
| Acadian asset management | 121.03K | 1.80% | $686.00K |
| Goldman sachs group | 91.53K | 1.36% | $519.87K |
| Blackrock funding, inc. /de | 60.07K | 0.89% | $341.20K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Artal group | 2.83M | 0.20% | $7.98M |
| Deltec asset management | 32.65K | 0.03% | $185.45K |
| Palo alto investors lp | 15.05K | 0.02% | $92.09K |
| Accent capital management | 38.00 | 0.01% | $23.37K |
| Drw securities | 43.81K | 0.01% | $248.85K |
| Abel hall | 23.57K | 0.00% | $7.54K |
| Renaissance | 287.61K | 0.00% | $1.63M |
| Acadian asset management | 121.03K | 0.00% | $686.00K |
| Bank of america corp /de/ | 2.98M | 0.00% | $8.41M |
| Cubist systematic strategies | 19.05K | 0.00% | $53.71K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.29M | 0.00% | 245.40K |
| Wellington management group llp | 119.36K | 0.00% | 119.36K |
| Drw securities | 43.81K | 0.01% | 43.81K |
| Deltec asset management | 32.65K | 0.03% | 32.65K |
| Abel hall | 23.57K | 0.00% | 23.57K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | - | - | -8.46M |
| Bellevue group | - | - | -3.92M |
| Siren | - | - | -2.97M |
| Fmr | - | - | -2.35M |
| Ecor1 capital | - | - | -2.05M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Wellington management group llp | 119.36K | 0.00% | 119.36K | $336.58K |
| Drw securities | 43.81K | 0.01% | 43.81K | $248.85K |
| Deltec asset management | 32.65K | 0.03% | 32.65K | $185.45K |
| Abel hall | 23.57K | 0.00% | 23.57K | $7.54K |
| Susquehanna group, llp | 22.79K | - | 22.79K | $24.16K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -9.00 |
| Eversource wealth advisors | -27.00 |
| Srs capital advisors | -38.00 |
| Capital performance advisors llp | -45.00 |
| Gamma investing | -50.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 11 | -71.79% | 779,217 | -80.37% | 11 | 0.33% | 4 | -50.00% | 4 | -86.21% |
| Sep 30, 2025 | 1 | -98.31% | 38 | -100.00% | - | - | - | -100.00% | - | -100.00% |
| Jun 30, 2025 | 58 | -28.40% | 41,332,317 | 4.83% | 61 | 1.78% | 23 | -4.17% | 25 | -34.21% |
| Mar 31, 2025 | 82 | 1.23% | 47,707,211 | -11.41% | 71 | 1.09% | 24 | -38.46% | 38 | 100.00% |
| Dec 31, 2024 | 20 | -73.33% | 12,890,700 | -76.66% | 19 | 0.28% | 7 | -73.08% | 5 | -81.48% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 4.76M | 7.09% | -509.39K |
| T. Rowe Price New Horizons | 475.51K | 7.06% | -1.00 |
| BB Biotech AG Ord | 3.92M | 5.87% | - |
| Fidelity Growth Compy Commingled Pl O | 1.94M | 2.91% | - |
| Vanguard US Total Market Shares ETF | 1.56M | 2.32% | - |
| Vanguard Total Stock Mkt Idx Inv | 152.41K | 2.26% | - |
| T. Rowe Price Health Sciences | 111.48K | 1.65% | -8.76K |
| T. Rowe Price New Horizons Tr-Z | 1.04M | 1.56% | 2.03K |
| Fidelity Growth Company Fund | 972.42K | 1.45% | -380.52K |
| Fidelity Growth Compy Commingled Pl S | 873.41K | 1.30% | -461.25K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 10, 2025 | Quinn Anthony G. | - | Buy | $120.76K |
| Jan 13, 2025 | Quinn Anthony G. | - | Buy | $82.45K |
| Jul 01, 2024 | Paone Antoinette | CHIEF OPERATING OFFICER | Sell | $18.41K |
| Jan 02, 2024 | Paone Antoinette | CHIEF OPERATING OFFICER | Sell | $3.96K |
| Jan 02, 2024 | Samayoa Phillip | CHIEF STRATEGY OFFICER | Sell | $3.96K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 2 | - |
GBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools